The efficacy of trimetazidine combined isosorbide dinitrate on the levels of ET and cEMPs in patients with angina pectoris
朱宏旭,宋丽萍,刘庚,耿学峰,常宇锋
DOI: https://doi.org/10.3969/j.issn.1671-4695.2018.07.025
2018-01-01
Abstract:Objective To explore the effect of trimetazidine and isosorbide dinitrate on levels of endothelin (ET) and circulating endothelial microparticles (cEMPs) in patients with angina pectoris. Methods One hundred patients with angina pectoris in this hospital during December 2013 to December 2016 were selected for this prospective study,all these patients were divided into isosorbide group and combination treatment group according to the method of treatment, each group with 50 patients. Patients in isosorbide group were given with isosorbide dinitrate for treatment, and patients in combination treatment group were given with trimetazidine on the basis of treatment in isosorbide group. The serum levels of ET, cEMPs, and cardiac output (SV),ejection fraction (EF),frequency and duration of angina attack,and adverse reactions were observed and compared between these two groups before and after treatment. Results After treatment,levels of ET and cEMPs and frequency of attack, sustained time [ (66.11 ±6.80) μg/ml,(833.47 ±86.97) ×l06/L,(2.67 ±0.36) times/week, (4.28 ±1.34) min/time and (81.43 ±8.45)μg/ml, (1 031.76 ± 107.01) × 106/L,(1.27 ±0.28) times/week,(8. 67 ± 1.78) min/time) ] of isosorbide group and combination group were significantly lower than those before treatment [ (121.75 ± 14.61) μg/ml,(1 220.52 ± 30.97) × 106/L, (7.59 ± 2.23) times /week,(22.12±4.07) min/time and (120.45±14.13) μg/ml,(1 223.13 ±131.43) ×l06/L, (7.53±2.18) times/week, (22.43 ±4.11) min/ time) ], after treatment, levels of ET and cEMPs and frequency of attack in combination group were significantly lower than those of isosorbide group, after treatment heart stroke volume (SV), ejection fraction (EF) levels [ (70.43 ± 7.24) ml, were (60.94 ±6.31)％ and (62.47 ±6.58) ml, (55.12 ±5.45) ％ ] in isosorbide group and combination group were significantly higher than those before treatment [ (46.13 ±4.86) ml, (48.69 ±5.24) ％ and (46.24±4.82) ml, (48.78 ±5.28)％ ], after treatment, levels of SV and EF in combination group were significantly higher than those of isosorbide group,and the difference was statistically significant (P ＜0.05). The rates of adverse reactions in isosorbide group (16.00％ ) and combination group (12.00％ ) were basically the same, and the difference was not statistically significant (P ＞0.05). Conclusion The application of trimetazidine combined with isosorbate dinitrate for treatment can effectively improve the endothelial function and myocardial contractile force of patients with angina pectoris, and it is helpful to reduce the frequency of attack and duration of angina of patients with good safety, hence it is worthy to be applied for further clinical application.